Truly Translational is founded on solid scientific expertise and more than 50 years’ experience of drug research & development in both large pharma and biotech. We help our customers to bring drug projects from preclinical in vitro studies and animal models, via common biomarker strategies, into concept testing in patients.
We have solid experience in working with both small and large molecules. Our key therapeutic areas are inflammation, respiratory diseases, autoimmune diseases and oncology. As a member of the Medicon Valley Inhalation Consortium we possess access to unique competence and capabilities within inhalation, where Truly Labs offers pre-clinical in vivo inhalation pharmacology services.